Preeclampsia is a major cause of maternal and perinatal morbidity and mortality. Early-onset
disease requiring preterm delivery is associated with a higher risk of complications in both …

Preeclampsia is a serious complication of pregnancy where it affects 5–8% of all
pregnancies. It increases the morbidity and mortality of both the fetus and pregnant woman …

Objective To examine the performance of screening for early, preterm and term pre‐
eclampsia (PE) at 11–13 weeks' gestation by maternal factors and combinations of mean …

Objective To test the hypothesis that the performance of first‐trimester screening for pre‐
eclampsia (PE) by a method that uses Bayes' theorem to combine maternal factors with …

Objective: To develop models for prediction of preeclampsia (PE) based on maternal
characteristics, biophysical and biochemical markers at 11–13 weeks' gestation in which the …

The established method of the assessment of the risk for development of preeclampsia is to
identify risk factors from maternal demographic characteristics and medical history; in the …

Effective screening for the development of early onset preeclampsia (PE) can be provided in
the first‐trimester of pregnancy. Screening by a combination of maternal risk factors, uterine …

Point-of-care testing (POCT) is a laboratory-medicine discipline that is evolving rapidly in
analytical scope and clinical application. In this review, we first describe the state of the art of …

Objective To compare early vs late administration of low‐dose aspirin on the risk of perinatal
death and adverse perinatal outcome. Methods Databases were searched for keywords …

Objectives To determine the accuracy with which uterine artery Doppler in the first trimester
of pregnancy predicts pre‐eclampsia and fetal growth restriction, particularly early‐onset …